Quantum Cyber N.V. Insurance Revenue Amounts Relating To Changes In Liability For Remaining Coverage
Quantum Cyber N.V. (QUCY) reported Insurance Revenue Amounts Relating To Changes In Liability For Remaining Coverage of $1.13 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-09.
Discontinued › Income Statement › Other Income
ifrs-full:InsuranceRevenueAmountsRelatingToChangesInLiabilityForRemainingCoverage · last filed 2024-04-09
| Period end | Insurance Revenue Amounts Relating To Changes In Liability For Remaining Coverage 12 month |
|---|---|
| 2023-12-31 | $1.13M 20-F · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |